{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:56:29Z","timestamp":1793854589119,"version":"4.6.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bbagen.2021.130067","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T11:10:11Z","timestamp":1638961811000},"page":"130067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Apoferritin and Dps as drug delivery vehicles: Some selected examples in oncology"],"prefix":"10.1016","volume":"1866","author":[{"given":"Anchala I.","family":"Kuruppu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Turyanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey D.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandula Prasanna","family":"Galhena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyani","family":"Paranagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranil","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2021.130067_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"Jong","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2021.130067_bb0010","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front.Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0015","series-title":"Applied Spectroscopy and the Science of Nanomaterials","first-page":"253","article-title":"Nanomaterials in nanomedicine","author":"Mensah","year":"2014"},{"key":"10.1016\/j.bbagen.2021.130067_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13643-018-0823-5","article-title":"Nanomedicine for drug delivery in South Africa: a protocol for systematic review","volume":"7","author":"Saidi","year":"2018","journal-title":"Syst.Rev."},{"key":"10.1016\/j.bbagen.2021.130067_bb0025","first-page":"512","article-title":"The nanomedicine revolution","volume":"37","author":"Ventola","year":"2012","journal-title":"Pharm.Ther."},{"key":"10.1016\/j.bbagen.2021.130067_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2867-10-11","article-title":"From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer","volume":"10","author":"Knox","year":"2010","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbagen.2021.130067_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"Cancer J.Clin."},{"key":"10.1016\/j.bbagen.2021.130067_bb0040","series-title":"Side Effects Chemotherapy","year":"2017"},{"key":"10.1016\/j.bbagen.2021.130067_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin.Transl.Med."},{"key":"10.1016\/j.bbagen.2021.130067_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2020.00079","article-title":"Nanoscale drug delivery systems: from medicine to agriculture","volume":"8","author":"Vega-Vasquez","year":"2020","journal-title":"Front.Bioeng.Biotechnol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0060","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bbagen.2021.130067_bb0065","series-title":"Protein-Nanoparticle Interactions","first-page":"1","author":"Rahman","year":"2013"},{"key":"10.1016\/j.bbagen.2021.130067_bb0070","series-title":"Nanocarriers for Drug Delivery","first-page":"395","author":"Mohapatra","year":"2019"},{"key":"10.1016\/j.bbagen.2021.130067_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/pharmaceutics13020155","article-title":"Nanomaterials for protein delivery in anticancer applications","volume":"13","author":"Yau","year":"2021","journal-title":"Pharmaceutica"},{"key":"10.1016\/j.bbagen.2021.130067_bb0080","series-title":"Nanomedicine in Drug Delivery","first-page":"1","author":"Kumar","year":"2013"},{"key":"10.1016\/j.bbagen.2021.130067_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2021.130067_bb0090","first-page":"1","article-title":"Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles","volume":"33","author":"Singh","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbagen.2021.130067_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/1061186X.2018.1519029","article-title":"Stimuli-responsive nanoscale drug delivery systems for cancer therapy","volume":"27","author":"Li","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbagen.2021.130067_bb0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11705-017-1620-8","article-title":"Functional ferritin nanoparticles for biomedical applications","volume":"11","author":"Wang","year":"2017","journal-title":"Front. Chem. Sci. Eng."},{"key":"10.1016\/j.bbagen.2021.130067_bb0105","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1039\/D0CS01349H","article-title":"Redesign of protein nanocages: the way from 0D, 1D, 2D to 3D assembly","volume":"50","author":"Lv","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbagen.2021.130067_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10020328","article-title":"Selective targeting of cancer-associated fibroblasts by engineered H-ferritin nanocages loaded with navitoclax","volume":"10","author":"Sitia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2021.130067_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10091894","article-title":"Ferritin nanocage: a versatile nanocarrier utilized in the field of food, nutrition, and medicine","volume":"10","author":"Zhang","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bbagen.2021.130067_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nbt.2014.12.006","article-title":"Ferritin family proteins and their use in bionanotechnology","volume":"32","author":"He","year":"2015","journal-title":"New Biotechnol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/genes9070370","article-title":"Bioengineering strategies for protein-based nanoparticles","volume":"9","author":"Diaz","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.bbagen.2021.130067_bb0130","first-page":"1","article-title":"Protein-based engineered nanostructures","author":"Cortajarena","year":"2016"},{"key":"10.1016\/j.bbagen.2021.130067_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/180549","article-title":"Protein nanoparticles as drug delivery carriers for cancer therapy","volume":"2014","author":"Lohcharoenka","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbagen.2021.130067_bb0140","first-page":"262","article-title":"Nanoparticle albumin - bound (NAB) technology is a promising method for anti-cancer drug delivery, recent patents on anti-cancer","volume":"4","author":"Fu","year":"2009","journal-title":"Drug Discov."},{"key":"10.1016\/j.bbagen.2021.130067_bb0145","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41467-019-08788-9","article-title":"Disulfide-mediated conversion of 8-mer bowl-like protein architecture into three different nanocages","volume":"10","author":"Zang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagen.2021.130067_bb0150","first-page":"1","article-title":"Protein based nanostructures for drug delivery","volume":"2018","author":"Verma","year":"2018","journal-title":"J.Pharm."},{"key":"10.1016\/j.bbagen.2021.130067_bb0155","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1039\/C7CS00818J","article-title":"Protein cage assembly across multiple length scales","volume":"47","author":"Aumiller","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbagen.2021.130067_bb0160","doi-asserted-by":"crossref","first-page":"14268","DOI":"10.1039\/C8RA00911B","article-title":"Near infrared dye loaded copper sulfide-apoferritin for tumor imaging and photothermal therapy","volume":"8","author":"He","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbagen.2021.130067_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/nnm.12.185","article-title":"Nanoparticles for imaging and treating brain cancer","volume":"8","author":"Meyers","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.bbagen.2021.130067_bb0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbagen.2008.09.004","article-title":"Ferritins: a family of molecules for iron storage, antioxidation and more","volume":"1790","author":"Arosio","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2021.130067_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.03.002","article-title":"Ferritin nanocages: a biological platform for drug delivery, imaging and theranostics in cancer","volume":"107","author":"Truffi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2021.130067_bb0185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.str.2005.01.019","article-title":"Crystal structures of a tetrahedral open pore ferritin from the hyperthermophilic archaeon archaeoglobus fulgidus","volume":"13","author":"Johnson","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.bbagen.2021.130067_bb0190","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/molecules25040825","article-title":"Ferritin nanocages for protein delivery to tumor cells","volume":"25","author":"Palombarini","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2021.130067_bb0195","first-page":"1","article-title":"Chemistry and biology of ferritin","volume":"12","author":"Plays","year":"2021","journal-title":"Metallomics"},{"key":"10.1016\/j.bbagen.2021.130067_bb0200","series-title":"Crystallization, Biomineralization, Chemistry, Molecular Sciences and Chemical Engineering","first-page":"940","author":"Volkmer","year":"2003"},{"key":"10.1016\/j.bbagen.2021.130067_bb0205","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1039\/b810949d","article-title":"Apoferritin protein cages: a novel drug nanocarrier for photodynamic therapy","volume":"2008","author":"Yan","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbagen.2021.130067_bb0210","doi-asserted-by":"crossref","first-page":"8700","DOI":"10.1039\/c0jm04321d","article-title":"Apoferritin-based nanomedicine platform for drug delivery: equilibrium binding study of daunomycin with DNA","volume":"21","author":"Ma-Ham","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113892","article-title":"Ferritin nanocage: a promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrier","volume":"176","author":"Zhang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbagen.2021.130067_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.msec.2018.10.060","article-title":"Apoferritin nanocages with Au nanoshell coating as drug carrier for multistimuli-responsive drug release","volume":"95","author":"Li","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bbagen.2021.130067_bb0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2016.03.023","article-title":"Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression","volume":"232","author":"Lei","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2021.130067_bb0230","doi-asserted-by":"crossref","first-page":"14900","DOI":"10.1073\/pnas.1407808111","article-title":"H-ferritin\u2013nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection","volume":"111","author":"Liang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2021.130067_bb0235","first-page":"3409","article-title":"Encapsulation of platinum anticancer drugs by apoferritin","volume":"33","author":"Yang","year":"2007","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbagen.2021.130067_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2016.05.006","article-title":"Comparison of two endogenous delivery agents in cancer therapy: exosomes and ferritin","volume":"110","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2021.130067_bb0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nchembio.1163","article-title":"Re-engineering protein interfaces yields copper-inducible ferritin cage assembly","volume":"9","author":"Huard","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0250","article-title":"Development of novel apoferritin formulations for antitumour benzothiazoles","volume":"2","author":"Breen","year":"2019","journal-title":"Cancer Rep."},{"key":"10.1016\/j.bbagen.2021.130067_bb0255","doi-asserted-by":"crossref","first-page":"36699","DOI":"10.1039\/C9RA07161J","article-title":"Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells","volume":"9","author":"Junior","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbagen.2021.130067_bb0260","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/adhm.201500389","article-title":"An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib","volume":"18","author":"Kuruppu","year":"2015","journal-title":"Adv.Healthc.Mater."},{"key":"10.1016\/j.bbagen.2021.130067_bb0265","doi-asserted-by":"crossref","first-page":"9525","DOI":"10.2147\/IJN.S226293","article-title":"Protein encapsulation of experimental anticancer agents 5F 203 and phortress: towards precision drug delivery","volume":"14","author":"Breen","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2021.130067_bb0270","first-page":"834","article-title":"The ferritin superfamily: supramolecular templates for materials synthesis","volume":"2013","author":"Uchida","year":"1800","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2021.130067_bb0275","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1002\/anie.201609517","article-title":"Conversion of the native 24-mer ferritin nanocage into its non-native 16-mer analogue by insertion of extra amino acid residues","volume":"55","author":"Zhang","year":"2016","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.blre.2008.08.001","article-title":"Ferritin for the clinician","volume":"23","author":"Knovich","year":"2009","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbagen.2021.130067_bb0285","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jmmm.2005.01.066","article-title":"Magic ferritin: a novel chemotherapeutic encapsulation bullet","volume":"293","author":"Simsek","year":"2005","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.bbagen.2021.130067_bb0290","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2021.130067_bb0295","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1039\/C9NR03823J","article-title":"Ferritin variants: inspirations for rationally designing protein nanocarriers","volume":"11","author":"Jin","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbagen.2021.130067_bb0300","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1021\/acsami.7b13431","article-title":"Panitumumab-conjugated and platinum-cored pH-sensitive apoferritin nanocages for colorectal cancer-targeted therapy","volume":"10","author":"Lin","year":"2018","journal-title":"Appl.Mater.Interf."},{"key":"10.1016\/j.bbagen.2021.130067_bb0305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.bi.49.070180.002041","article-title":"Iron transport and storage proteins","volume":"49","author":"Aisen","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2019.12.010","article-title":"Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment","volume":"323","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2021.130067_bb0315","series-title":"Nanotechnology-based Targeted Drug Delivery Systems for Brain Tumors","first-page":"267","article-title":"Dendrimers as effective carriers for the treatment of brain tumor","author":"Gorain","year":"2018"},{"key":"10.1016\/j.bbagen.2021.130067_bb0320","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/17425247.2016.1224848","article-title":"Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system?","volume":"10","author":"Tosi","year":"2016","journal-title":"Expert Opin.Drug Deliv."},{"key":"10.1016\/j.bbagen.2021.130067_bb0325","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood\u2013brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbagen.2021.130067_bb0330","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1021\/acs.molpharmaceut.7b00341","article-title":"Apoferritin nanocage for brain targeted doxorubicin delivery","volume":"14","author":"Chen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagen.2021.130067_bb0335","first-page":"2032","article-title":"H-ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies","volume":"9","author":"Rizzuto","year":"2021","journal-title":"biomaterialsScience"},{"key":"10.1016\/j.bbagen.2021.130067_bb0340","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2021.130067_bb0345","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2014.03.004","article-title":"Coming full circle-from endless complexity to simplicity and back againr","volume":"157","author":"Weinberg","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2021.130067_bb0350","first-page":"1","article-title":"The Role of HER Family Signalling in Breast Cancer","author":"Kuruppu","year":"2016"},{"key":"10.1016\/j.bbagen.2021.130067_bb0355","series-title":"Gefitinib","author":"Pubchem","year":"2021"},{"key":"10.1016\/j.bbagen.2021.130067_bb0360","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","article-title":"Role of epidermal growth factor receptor in breast cancer","volume":"136","author":"Masuda","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbagen.2021.130067_bb0365","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.2174\/092986711797200453","article-title":"New strategies in the discovery of novel non-camptothecin topoisomerase I inhibitors","volume":"18","author":"Sheng","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0370","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/pharmaceutics12100992","article-title":"Engineered human nanoferritin bearing the drug Genz-644282 for cancer therapy","volume":"12","author":"Falvo","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbagen.2021.130067_bb0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-021-01851-8","article-title":"High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors","volume":"40","author":"Falvo","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2021.130067_bb0380","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jsps.2019.02.004","article-title":"Medicinal plants commonly used against cancer in traditional medicine formulae in Sri Lanka","volume":"27","author":"Kuruppu","year":"2019","journal-title":"Saudi Pharm.J."},{"key":"10.1016\/j.bbagen.2021.130067_bb0385","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4172\/2157-7439.1000519","article-title":"Advances in delivery systems for doxorubicin","volume":"9","author":"Zhao","year":"2018","journal-title":"J.Nanomed.Nanotechnol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0390","series-title":"Doxorubicin","author":"PubChem","year":"2020"},{"key":"10.1016\/j.bbagen.2021.130067_bb0395","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2014.10.002","article-title":"Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in cancer cells","volume":"196","author":"Bellini","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2021.130067_bb0400","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1038\/s41598-020-68205-w","article-title":"Co-administration of H ferritin doxorubicin and trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2+ murine breast cancer model","volume":"10","author":"Andreata","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2021.130067_bb0405","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/abbi.2000.2068","article-title":"Production of recombinant human apoferritin heteromers","volume":"384","author":"Grace","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2021.130067_bb0410","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2015.11.018","article-title":"Expression, purification, and characterization of recombinant human L-chain ferritin","volume":"119","author":"Zou","year":"2016","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbagen.2021.130067_bb0415","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/156802606776287081","article-title":"Inhibitors of cysteine proteases","volume":"6","author":"Vicik","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0420","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbagen.2021.130067_bb0425","doi-asserted-by":"crossref","first-page":"12609","DOI":"10.1021\/acsami.0c01514","article-title":"Delivery of temozolomide and N3-propargyl analog to brain tumors using an apoferritin nanocage","volume":"12","author":"Bouzinab","year":"2020","journal-title":"ACS Appl.Mater.Interf."},{"key":"10.1016\/j.bbagen.2021.130067_bb0430","doi-asserted-by":"crossref","first-page":"35266","DOI":"10.1021\/acsami.1c04164","article-title":"Chemosensitization of temozolomide-resistant pediatric diffuse midline glioma using potent nanoencapsulated forms of a N(3)-propargyl analogue","volume":"13","author":"Shargh","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbagen.2021.130067_bb0435","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-00925-1","article-title":"Integrin \u03b12\u03b21-targeting ferritin nanocarrier traverses the blood\u2013brain barrier for effective glioma chemotherapy","volume":"19","author":"Huang","year":"2021","journal-title":"J.Nanobiotechnol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0440","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/21691401.2018.1516671","article-title":"Development and characterization of folic acid-functionalized apoferritin as a delivery vehicle for epirubicin against MCF-7 breast cancer cells","volume":"46","author":"Alqaraghuli","year":"2018","journal-title":"Artif.Cells Nanomed.Biotechnol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0445","series-title":"Epirubicin","author":"USA","year":"2020"},{"key":"10.1016\/j.bbagen.2021.130067_bb0450","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3747\/co.v18i1.708","article-title":"Oxaliplatin: a review in the era of molecularly targeted therapy","volume":"18","author":"Alcindor","year":"2011","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0455","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2741\/s532","article-title":"Anticancer potential of natural products: a review focusing on Sri Lankan plants","volume":"11","author":"Kuruppu","year":"2019","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbagen.2021.130067_bb0460","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2004.07.013","article-title":"Role of chemopreventive agents in cancer therapy","volume":"215","author":"Dorai","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2021.130067_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110982","article-title":"Efficient synergistic combination effect of quercetin with curcumin on breast cancer cell apoptosis through their loading into apo ferritin cavity","volume":"191","author":"Mansourizadeh","year":"2020","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.bbagen.2021.130067_bb0470","series-title":"Anti-cancer potential of flavonoids: recent trends and future perspectives","first-page":"439","author":"Batra","year":"2013"},{"key":"10.1016\/j.bbagen.2021.130067_bb0475","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1039\/C7TB02912H","article-title":"Stable DHLA\u2013PEG capped PbS quantum dots: from synthesis to near-infrared biomedical imaging","volume":"6","author":"Zamberlan","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbagen.2021.130067_bb0480","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1039\/c3tb21197e","article-title":"Apoferritin-encapsulated PbS quantum dots significantly inhibit growth of colorectal carcinoma cells","volume":"1","author":"Bradshaw","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbagen.2021.130067_bb0485","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.4103\/0975-7406.137249","article-title":"Theranostics: a treasured tailor for tomorrow","volume":"6","author":"Jeelani","year":"2014","journal-title":"J.Pharm.Bioallied Sci."},{"key":"10.1016\/j.bbagen.2021.130067_bb0490","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2310\/7290.2011.00031","article-title":"Comparative study of the optical and heat generation properties of IR820 and indocyanine green","volume":"11","author":"Fernandez-Fernandez","year":"2012","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.bbagen.2021.130067_bb0495","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1002\/adma.201400914","article-title":"Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy","volume":"26","author":"Huang","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbagen.2021.130067_bb0500","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/smll.200900017","article-title":"The biocompatibility of apoferritin-encapsulated PbS quantum dots","volume":"3","author":"Turyanska","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.bbagen.2021.130067_bb0505","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1039\/C1JM13563E","article-title":"The differential effect of apoferritin-PbS nanocomposites on cell cycle progression in normal and cancerous cells","volume":"22","author":"Turyanska","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0510","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/834139","article-title":"Application of quantum dots in biological imaging","volume":"2011","author":"Jin","year":"2011","journal-title":"J. Nanomater."},{"key":"10.1016\/j.bbagen.2021.130067_bb0515","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1101\/gad.6.12b.2646","article-title":"A novel DNA-binding protein with regulatory and protective roles in starved Escherichia coli","volume":"6","author":"Almiron","year":"1992","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagen.2021.130067_bb0520","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/pro.731","article-title":"Rational disruption of the oligomerization of the mini-ferritin E. coli dps through protein-protein interface mutation","volume":"20","author":"Zhang","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2021.130067_bb0525","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00018-009-0168-2","article-title":"Dps-like proteins: structural and functional insights into a versatile protein family","volume":"67","author":"Haikarainen","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbagen.2021.130067_bb0530","article-title":"Listeria innocua dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX","volume":"20","author":"Al-Ani","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbagen.2021.130067_bb0535","series-title":"Advances in Applied Microbiology","first-page":"1","author":"Gadd","year":"2021"},{"key":"10.1016\/j.bbagen.2021.130067_bb0540","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/JB.00475-15","article-title":"The DNA-binding protein from starved cells (Dps) utilizes dual functions to defend cells against multiple stresses","volume":"197","author":"Karas","year":"2015","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0545","first-page":"1","article-title":"Morphological peculiarities of the DNA-protein complexes in starved Escherichia coli cells","volume":"5","author":"Loiko","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2021.130067_bb0550","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2672.2010.04890.x","article-title":"Structure, function and regulation of the DNA-binding protein dps and its role in acid and oxidative stress resistance in Escherichia coli: a review","volume":"110","author":"Calhoun","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2019.125097","article-title":"Fabrication, structure, and function evaluation of the ferritin based nanocarrier for food bioactive compounds","volume":"299","author":"Liu","year":"2019","journal-title":"Food Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0560","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/JB.186.13.4192-4198.2004","article-title":"Dps protects cells against multiple stresses during stationary phase","volume":"186","author":"Nair","year":"2020","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbagen.2021.130067_bb0565","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1172\/JCI127511","article-title":"The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration","volume":"129","author":"Uchida","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2021.130067_bb0570","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1074\/jbc.M113.524421","article-title":"A histidine aspartate ionic lock gates the iron passage in miniferritins from Mycobacterium smegmatis","volume":"289","author":"Williams","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2021.130067_bb0575","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s12276-021-00599-7","article-title":"Tailoring photosensitive ROS for advanced photodynamic therapy","volume":"53","author":"Sai","year":"2021","journal-title":"Exp.Mol.Med."},{"key":"10.1016\/j.bbagen.2021.130067_bb0580","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apsb.2020.09.016","article-title":"Recent advances in drug delivery systems for targeting cancer stem cells","volume":"11","author":"Duan","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbagen.2021.130067_bb0585","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1298473","article-title":"Immunogenicity of biotherapeutics: causes and association with posttranslational modifications","volume":"2016","author":"Kuriakose","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbagen.2021.130067_bb0590","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/14737140.2021.1910027","article-title":"Apoferritin: a potential nanocarrier for cancer imaging and drug delivery","volume":"21","author":"Veroniaina","year":"2021","journal-title":"Expert. Rev. Anticancer Ther."},{"key":"10.1016\/j.bbagen.2021.130067_bb0595","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s13238-017-0481-8","article-title":"Questions about horse spleen ferritin crossing the blood brain barrier via mouse transferrin receptor 1","volume":"8","author":"Fan","year":"2017","journal-title":"Protein Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416521002269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416521002269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:13:46Z","timestamp":1759637626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416521002269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0304416521002269"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2021.130067","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apoferritin and Dps as drug delivery vehicles: Some selected examples in oncology","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2021.130067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130067"}}